The LifeFactFuture consortium includes the University of Turku, the University of Helsinki, Orion, some of Finland’s leading life science manufacturers, and data and technology companies.

The project, led by the University of Turku and for which Business Finland recently granted EUR 11.7 million funding, seeks to enhance advanced pharmaceutical and life science manufacturing in Finland. The funding decision is among the largest received at the University of Turku in the history of Business Finland.

The funding decision is among the largest received at the University of Turku in the history of Business Finland.”

“The LifeFactFuture project focuses on the ways that pharmaceutical manufacturing can be advanced by utilizing new technologies. This project is a great opportunity for Orion to actively participate in understanding and improving the capabilities of new technologies, and therefore also continuously enhancing competitiveness,” says Juhani Kankaanpää, Orion’s Senior Vice President for Global Operations,

Three key areas

The goal of the project collaboration is to speed up the introduction of digital solutions and more efficient utilization of data and to make Finland the most attractive place in the world for investments in life science manufacturing.

Make Finland the most attractive place in the world for investments in life science manufacturing.”

The project consists of three key areas: Roadmap for Data Utilization, Imaging Combined with AI Solutions, and Monitoring and Process Control.

Project collaborators

In the project’s funding decision, Business Finland states that the unique consortium expertise can make Finland a strategic and profitable manufacturing country and improve its position as a hub for global business ecosystems. The project strengthens the competitive advantage and ability of the companies in the field in international markets and aims to increase turnover for both the life science and technology industries.

Three major players in the life science industry, Bayer, Orion, and Revvity, have their own projects within the consortium. In addition, the LifeFactFuture consortium includes the technology sector with Brightly Works, Bittium, Darekon, Nokia, and Vaisala involved in the consortium and a wide range of other subcontractors. The project is linked to Bittium’s Seamless and Secure Connectivity Business Finland Veturi project and its theme of significant development of operational models that promote the agile development of medical software (RegOps).

In addition, the Finnish Medicines Agency, Fimea, is involved in the project to ensure compliance between technological development and pharmaceutical legislation.

Photo: iStock